AlphAIalphai — Financial news for AI agents
SEC EDGARAUG 251 min read$JHX

Singh Jesse G sold $16.0M of JHX

Singh Jesse G sold 530,100 shares of James Hardie Industries plc (JHX) at an average of $30.21 ($30.19–$30.23, $16.01M total) across 2 trades over 2026-08-21 to 2026-08-24.

Original reporting
SEC EDGAR · Singh Jesse G
Published Aug 25, 2026, 8:10 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 25, 2026, 8:38 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$JHX
Bearish
medium confidence
Mentioned
$JHX
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$JHXBearishLow
01

Why it matters

The disclosed insider sale provides fresh material for traders assessing short-term price pressure.

02

Market read

First-report insider sale of $16M by a director; may influence short-term trading sentiment.

03

What to watch

No public statement from the director; could be tax planning or portfolio rebalancing.

Relevance 7/10Novelty 8/10Timing: filed today

Background

James Hardie Industries plc (JHX) is a global building products company listed in the US as an ADR.

Company-level read

Ticker impact

$JHXBearishMedium confidence
Context

Director Jesse G. Singh sold 530,100 shares for $16.0M, reducing his stake to 117,028 shares.

Expected impact

Possible modest downside pressure in the near term.

Evidence & confidence

The sale size ($16M) is material for a director, but no accompanying statement explains motive.

Market effects

Sector

Minimal; insider sale does not affect the broader building materials sector.

Regional

Limited to investors tracking James Hardie.

Global

Low

Counterpoint

What could challenge this read

The sale could be a routine liquidity event unrelated to company outlook.

Key entities

  • Company
    James Hardie Industries plc

    Building products manufacturer, ticker JHX.

  • Person
    Singh Jesse G.

    Director of James Hardie Industries plc.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

JHX insider trading history →

Related articles

AUG 24
$JHXHighAI 9/10

Fitch revises James Hardie outlook on European divestiture

Fitch affirmed James Hardie's 'BBB' rating and revised its outlook to Stable from Negative after the company agreed to sell its European business to Holcim for $980M. The deal, expected to close in 2027, includes the sale of Fermacell and the closure of its European fiber cement business. Fitch expects James Hardie's EBITDA leverage to decrease to 2.5x by FYE 2027, supported by debt paydown and sale proceeds. The European operations contributed 11.5% of revenue and 7.2% of EBITDA in fiscal 2026.

investing.com3 min
AUG 21
$JHXHighAI 9/10

James Hardie to sell Fermacell for €840m to Holcim

James Hardie will sell its European walling and flooring business, Fermacell, to Holcim for €840m. The company plans to close its European fibre cement business, focusing on North America. Proceeds will repay debt and fund a $250m share repurchase program. Holcim expects the deal to be earnings-accretive from 2027.

rte.ie2 min
AUG 21
$JHXHighAI 9/10

James Hardie ditches Europe, selling out to Holcim in $1.38b deal

James Hardie Industries is selling its Fermacell business in Europe to Holcim for €840 million ($1.38 billion) and exiting the region. The company will focus on its North American operations. According to James Hardie, the deal marks the end of its nine-year ownership of Fermacell.

afr.com1 min
AUG 20
$JHXHighAI 9/10

James Hardie Selling European Fermacell Business for $980 Million to Holcim

James Hardie Industries is selling its European Fermacell business to Holcim for $980 million, aiming to focus on higher-growth markets. The deal, expected to close in early 2027, will strengthen James Hardie's balance sheet and reduce debt. The company plans to use $600 million of the proceeds to repay debt and authorized a $250 million share repurchase program.

morningstar.com2 min